2023 annual financial data
Contineum Therapeutics 2023 Operating margin
Contineum Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -32.15%.
Operating income was -16,077,000 USD and net income was 22,720,000 USD.
Operating cash flow was 19,349,000 USD.
Get free Contineum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,000,000 USD
- Operating income
- -16,077,000 USD
- Net income
- 22,720,000 USD
- Operating cash flow
- 19,349,000 USD